WeVote
Log In

Bill

Bill

HB 169

AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE BEHAVIORAL HEALTH CONSORTIUM AND THE PRESCRIPTION OPIOID DISTRIBUTION COMMISSION.

153rd General Assembly (2025-2026) Introduced by Melissa Minor-Brown and 4 co-sponsors

Delaware modifies behavioral health and opioid oversight governance structures to improve state coordination of addiction services and prescription drug distribution management.

Signed by Governor
0
WeVote Research Nonpartisan
Bill Summary · HB 169

Legislative bill overview

HB 169 amends Delaware's Title 16 to modify the structure and operations of the Behavioral Health Consortium and the Prescription Opioid Distribution Commission. The bill restructures how these entities govern behavioral health services and opioid distribution oversight in the state.

Why is this important

Delaware's opioid crisis and behavioral health infrastructure require coordinated oversight mechanisms. This bill updates governance structures that directly affect how the state manages addiction services, prescription drug distribution, and behavioral health resources across state agencies and providers.

Potential points of contention

  • Governance changes: Modifications to the Consortium and Commission's composition or authority could shift power between state agencies, healthcare providers, and stakeholders, potentially affecting representation of certain groups
  • Implementation clarity: Without specific amendment details in public records, stakeholders may have concerns about how new procedures will function operationally and whether adequate transition support exists
  • Opioid distribution oversight: Changes to Commission authority could impact pharmaceutical supply chain monitoring, with questions about whether modifications strengthen or weaken prescription drug controls

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.